Harb Nathan, Foster Juliet M, Dobler Claudia C
South Western Sydney Clinical School, University of New South Wales.
Department of Respiratory Medicine, Liverpool Hospital.
Int J Chron Obstruct Pulmon Dis. 2017 Jun 1;12:1641-1652. doi: 10.2147/COPD.S130353. eCollection 2017.
While chronic morbidity and mortality from COPD is well documented, little is known about the treatment burden faced by patients with COPD.
Patients with severe airflow obstruction (forced expiratory volume in 1 second [FEV] <50% predicted) representing different age-groups, sex, and number of comorbidities participated in a semistructured interview. Interviews were conducted until thematic saturation was reached. Interviews were recorded, transcribed, and analyzed thematically using an established treatment-burden framework.
A total of 26 patients (42% male, mean age 66.7±9.8 years) with severe (n=15) or very severe (n=11) airflow limitation (mean FEV 32.1%±9.65% predicted) were interviewed. Participants struggled with various treatment-burden domains, predominantly with changing health behaviors, such as smoking cessation and exercise. Interviewees often only ceased smoking after a major health event, despite being advised to do so earlier by a doctor. Recommended exercise regimens, such as pulmonary rehabilitation classes, were curtailed, although some patients replaced them with light home-based exercise. Interviewees had difficulty attending medical appointments, often relying on others to transport them. Overall, COPD patients indicated they were not willing to accept the burden of treatments where they perceived minimal benefit.
This study describes the substantial treatment burden experienced by patients with COPD. Medical advice may be rejected by patients if the benefit of following the advice is perceived as insufficient. Health professionals need to recognize treatment burden as a source of nonadherence, and should tailor treatment discussions to fit patients' values and capacity to achieve optimal patient outcomes.
虽然慢性阻塞性肺疾病(COPD)的慢性发病率和死亡率已有充分记录,但对于COPD患者所面临的治疗负担却知之甚少。
代表不同年龄组、性别和合并症数量的严重气流受限(1秒用力呼气量[FEV1]<预计值的50%)患者参与了半结构化访谈。访谈持续进行直至达到主题饱和。访谈进行录音、转录,并使用既定的治疗负担框架进行主题分析。
共访谈了26例严重(n = 15)或极重度(n = 11)气流受限(平均FEV1为预计值的32.1%±9.65%)的患者(42%为男性,平均年龄66.7±9.8岁)。参与者在各种治疗负担领域都面临困难,主要是在改变健康行为方面,如戒烟和锻炼。受访者往往在经历重大健康事件后才戒烟,尽管医生 earlier曾建议他们早些戒烟。推荐的锻炼方案,如肺康复课程,有所减少,不过一些患者用轻度的家庭锻炼取而代之。受访者就医预约困难,常常依赖他人接送。总体而言,COPD患者表示,如果他们认为获益极小,就不愿意接受治疗负担。
本研究描述了COPD患者所经历的巨大治疗负担。如果患者认为遵循建议的益处不足,可能会拒绝医疗建议。卫生专业人员需要认识到治疗负担是不依从的一个原因,并且应该根据患者的价值观和能力调整治疗讨论,以实现最佳的患者治疗效果。